Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $202.30 | Total: $1,011.50 |
| 1 | 10 | $171.36 | Total: $1,713.60 |
| 1 | 25 | $145.18 | Total: $3,629.50 |
| 1 | 50 | $123.76 | Total: $6,188.00 |
| 1 | 100 | $107.10 | Total: $10,710.00 |
Overview
Zabicipril is a novel orally available angiotensin-converting enzyme inhibitor, a prodrug with antihypertensive activity following in vivo de-esterification.
Chemical Properties
| Molecular Formula | C23H32N2O5 |
| Molecular Weight | 416.51 |
| CAS Numbers | 83059-56-7 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C([C@@H](N[C@H](C(OCC)=O)CCC1=CC=CC=C1)C)(=O)N2[C@H](C(O)=O)C3(CCC2(CC3)[H])[H] |
Storage and Handling
0C Short Term, -20C Long Term
References
Naeije R, et al. Systemic and renal haemodynamic effects of angiotensin converting enzyme inhibition by zabicipril in young and in old normal men. Eur J Clin Pharmacol. 1993;44[1] 35-9.